Stephen Biggar
Président chez ACADIA PHARMACEUTICALS INC.
Fortune : 88 050 $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Stephen Davis | M | 63 | 13 ans | |
| Sanj Patel | M | 54 | 16 ans | |
| Felix Baker | M | 55 | 24 ans | |
| Gavin MacBeath | M | 54 | 6 ans | |
| R. Woods | M | 57 | 1 ans | |
| Rachel McMinn | M | 51 | 6 ans | |
| Eben Tessari | M | 42 | 10 ans | |
| Thomas Malley | M | 55 | 18 ans | |
| Barry Quart | M | 67 | 12 ans | |
| Timothy Barberich | M | 76 | 5 ans | |
| Michael Megna | M | 53 | 6 ans | |
| Jon Stonehouse | M | 63 | 17 ans | |
| Mark Ragosa | M | 50 | 6 ans | |
| George Abercrombie | M | 69 | 13 ans | |
| Katina Dorton | F | 66 | 3 ans | |
| Bob Mischler | M | - | 9 ans | |
| Tracey McCain | F | 56 | 6 ans | |
| Cory Freedland | M | 48 | 1 ans | |
| Peter Zandstra | M | - |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | 6 ans |
| Melissa Manno | F | - | 9 ans | |
| Mark Schneyer | M | 50 | 4 ans | |
| Zoran Zdraveski | M | 54 | 3 ans | |
| Rachel Frank | F | - | - | |
| Julian Baker | M | 57 | 9 ans | |
| Elizabeth Garofalo | M | 66 | 4 ans | |
| Brendan Teehan | M | 56 | 6 ans | |
| Gabriela Gruia | M | 67 | 3 ans | |
| Madelyn Zeylikman | F | - | 4 ans | |
| Julie Fisher | F | - | 6 ans | |
| Leiden Dworak | M | - | 2 ans | |
| Albert Kildani | M | - | 1 ans | |
| Barbara Klencke | M | 66 | 1 ans | |
| Sarah Noonberg | M | 56 | 1 ans | |
| William P. Sheridan | M | 69 | 16 ans | |
| Edmund Harrigan | M | 71 | 9 ans | |
| Rohan Palekar | M | 58 | 1 ans | |
| Jennifer J. Rhodes | F | 53 | - | |
| David Main | M | 59 |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | 4 ans |
| Robert Baffi | M | 68 | 1 ans | |
| Richard Levy | M | 66 | 5 ans | |
| Don Soland | M | 65 | 9 ans | |
| Kim Popovits | F | 65 | 6 ans | |
| Christine Cvijic | F | 46 | 1 ans | |
| Laura Brege | F | 66 | 16 ans | |
| G. Cole | M | 68 | 4 ans | |
| James Daly | M | 63 | 8 ans | |
| Alane Barnes | F | 58 | 18 ans | |
| Katherine Bishop | M | 58 | 3 ans | |
| Ray Lockard | M | - | 1 ans | |
| Benir Ruano | M | - | 2 ans | |
| Rob Ackles | M | - | 10 ans | |
| Ricardo Jimenez | M | - | - | |
| Julie Jordan | M | - | - | |
| Shrikanta Chattopadhya | M | - | - | |
| Kazenelson Deb | F | - | - | |
| Ann Hargraves | F | - | 4 ans | |
| Donna Cochener-Metcalfe | F | 49 | - | |
| Timothy Penner | M | 68 |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | - |
| Adora Ndu | M | 43 | 2 ans | |
| John Paolini | M | 59 | 8 ans | |
| Raf Hofstein | M | 74 |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | - |
| Andrew E. Mulberg | M | - | - | |
| Jason Amello | M | 55 | - | |
| Arvind Sreedharan | M | - | - | |
| Parag V. Meswani | M | - | 2 ans | |
| Martina Struck | M | - | 6 ans | |
| Stuart Cobb | M | 54 | 5 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Christopher Heberlig | M | 49 | 12 ans | |
| Thomas Beetham | M | 55 | 8 ans | |
| Christoph H. Westphal | M | 56 | 3 ans | |
| Thomas H. Aasen | M | 63 | 16 ans | |
| Brian Silver | M | 55 | 2 ans | |
| Uli Alf Hacksell | M | 74 | 15 ans | |
| Thomas Staab | M | 56 | 9 ans | |
| Stephen Mahoney | M | 53 | 7 ans | |
| Elena Ridloff | F | 44 | 3 ans | |
| Rasmus Holm-Jorgensen | M | 53 | 11 ans | |
| Michael A. Darwin | M | 62 | 8 ans | |
| David Southwell | M | 63 | 5 ans | |
| Carsten Boess | M | 57 | 9 ans | |
| Michael T. Borer | M | 65 | 11 ans | |
| Glenn F. Baity | M | 54 | 14 ans | |
| Amanda Morgan | F | - | - | |
| Michael Jones | M | 54 | 13 ans | |
| Brendan Classon | M | - | - | |
| Robert S. Lowrey | M | 63 | 2 ans | |
| Mary Gray | M | 71 | 11 ans | |
| James A. Nash | M | 73 | - | |
| Mark Goldberg | M | 69 | 6 ans | |
| Ittai Harel | M | 56 | 4 ans | |
| Leslie L. Iversen | M | 86 | 18 ans | |
| Torsten Erik Rasmussen | M | 78 | 17 ans | |
| William James Alexander | M | 74 | - | |
| Stanley Erck | M | 76 | 10 ans | |
| Charles E. Bugg | M | 82 | 21 ans | |
| Les Kaplan | M | 73 | 18 ans | |
| Kenneth Lee | M | 76 | 12 ans | |
| Peder K. Jensen | M | 69 | 4 ans | |
| William McDowall Wells | M | 63 | 4 ans | |
| Charlie Sanders | M | 91 | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 84 | 84,00% |
| Canada | 4 | 4,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Stephen Biggar
- Réseau Personnel
